Tissue distribution of quercetin in rats and pigs

Journal of Nutrition

Volumn 135, Issue 7, 2005, Pages 1718-1725

  De Boer, Vincent C J ^a   Dihal, Ashwin A ^a,b   Van Der Woude, Hester ^a   Arts, Ilja C W ^a   Wolffram, Siegfried ^c   Alink, Gerrit M ^a   Rietjens, Ivonne M C M ^a   Keijer, Jaap ^a   Hollman, Peter C H ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b TNO   (Netherlands)

^c UNIVERSITY OF KIEL   (Germany)

Author keywords

Flavonoids; Glucuronides; Polyphenols; Quercetin; Tissue distribution

Indexed keywords

CARBON 14; FLAVONOID; GLUCURONIDE; ISORHAMNETIN; POLYPHENOL DERIVATIVE; QUERCETIN; TAMARIXETIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; BRAIN; CONTROLLED STUDY; EXTRACTION; FEEDING; HALF LIFE TIME; HEART; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY; LUNG; MALE; METABOLITE; NONHUMAN; NUTRITION; RAT; SPLEEN; STATISTICAL ANALYSIS; SWINE; TISSUE DISTRIBUTION; WHITE ADIPOSE TISSUE;

SUS SCROFA;

EID: 22144495044     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/135.7.1718     Document Type: Article

References (43)

1. Arts, I.C.W. & Hollman, P.C.H. (2005) Polyphenols and disease risk in epidemiologic studies. Am. J. Clin. Nutr. 81: 317S-325S.
2. Hertog, M.G.L., Feskens, E.J.M., Hollman, P.C.H., Katan, M. B. & Kromhout, D. (1993) Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 342: 1007-1011.
3. Harborne, J. B. & Baxter, H., eds. (1999) The Handbook of Natural Flavonoids. John Wiley & Sons, Chichester, UK
4. Hertog, M.G.L., Hollman, P.C.H., Katan, M. B. & Kromhout, D, (1993) Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. Nutr. Cancer 20: 21-29.
5. Weldin, J., Jack, R., Dugaw, K. & Kapur, R. P. (2003) Quercetin, an over-the-counter supplement, causes neuroblastoma-like elevation of plasma homovaniliic acid. Pediatr. Dev. Pathol. 6: 547-551.
6. Manach, C., Scalbert, A., Morand, C., Rémésy, C. & Jimenez, L. (2004) Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr. 79: 727-747.
7. Williams, R. J., Spencer, J. P. & Rice-Evans, C. (2004) Flavonoids: antioxidants or signalling molecules? Free Radic. Biol. Med. 36: 838-849.
8. Yang, C. S., Landau, J. M., Huang, M. T. & Newmark, H. L. (2001) Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu. Rev. Nutr. 21: 381-406.
9. Middleton, E., Jr., Kandaswami, C. & Theoharides, T. C. (2000) The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 52: 673-751.
10. Nijveldt, R. J., van Nood, E., van Hoorn, D.E.G., Boelens, P. G., van Norren, K. & van Leeuwen, P.A.M. (2001) Flavonoids: a review of probable mechanisms of action and potential applications. Am. J. Clin. Nutr. 74: 418-425.
11. Kris-Etherton, P. M., Lefevre, M., Beecher, G. R., Gross, M. D., Keen, C. L. & Etherton, T. D. (2004) Bioactive compounds in nutrition and health-research methodologies for establishing biological function: the antioxidant and anti-inflammatory effects of flavonolds on atherosclerosis. Annu. Rev. Nutr. 24: 511-538.
12. Formica, J. V. & Regelson, W. (1995) Review of the biology of quercetin and related bioflavonoids. Food Chem. Toxicol. 33: 1061-1080.
13. Kroon, P. A., Clifford, M. N., Crozier, A., Day, A. J., Donovan, J. L., Manach, C. & Williamson, G. (2004) How should we assess the effects of exposure to dietary polyphenols in vitro? Am. J. Clin. Nutr. 80: 15-21.
14. Spencer, J. P., Rice-Evans, C. & Williams, R. J. (2003) Modulation of pro-survival Akt/protein kinase B and ERK1/2 signaling cascades by quercetin and its in vivo metabolites underlie their action on neuronal viability. J. Biol. Chem. 278: 34783-34793.
15. van der Woude, H., Boersma, M. G., Vervoort, J. & Rietjens, I. M. (2004) Identification of 14 quercetin phase II mono- and mixed conjugates and their formation by rat and human phase II in vitro model systems. Chem. Res. Toxicol. 17: 1520-1530.
16. Hollman, P.C.H. & Arts, I.C.W. (2000) Flavonols, flavones and flavanols-nature, occurrence and dietary burden. J. Sci. Food Agric. 80: 1081-1093.
17. Manach, C. & Donovan, J. L. (2004) Pharmacokinetics and metabolism of dietary flavonoids in humans. Free Radic. Res. 38: 771-785.
18. 14C] quercetin in the ACI rat. Jpn. J. Exp. Med. 53: 41-50.
19. Mullen, W., Graf, B. A., Caldwell, S. T., Hartley, R. C., Duthie, G. G., Edwards, C. A., Lean, M. E. & Crozier, A. (2002) Determination of flavonol metabolites in plasma and tissues of rats by HPLC-radiocounting and tandem mass spectrometry following oral ingestion of [2-(14)C]quercetin-4′-glucoside. J. Agric. Food Chem. 50: 6902-6909.
20. Manach, C., Texier, O., Morand, C., Crespy, V., Regerat, F., Demigné, C. & Rémésy, C. (1999) Comparison of the bioavailability of quercetin and catechin in rats. Free Radic. Biol. Med. 27: 1259-1266.
21. Morrice, P. C., Wood, S. G. & Duthie, G. G. (2000) High-performance liquid chromatographic determination of quercetin and isorhamnetin in rat tissues using beta-glucuronidase and acid hydrolysis. J. Chromatogr. B. Biomed. Sci. Appl. 738: 413-417.
22. Arts, I.C.W., Venema, D. P. & Hollman, P.C.H. (2003) Quantitative determination of flavonols in plant foods and biological fluids. In: Methods in Polyphenol Analysis (Santos Buelga, C. & Williamson, G., eds.), pp. 214-228. The Royal Society of Chemistry, Cambridge, UK.
23. Dahlberg, E. (1983) Estimation of the blood contamination of tissue extracts. Anal. Biochem. 130: 108-113.
24. Peng, H. W., Cheng, F. C., Huang, Y. T., Chen, C. F. & Tsai, T. H. (1998) Determination of naringenin and its glucuronide conjugate in rat plasma and brain tissue by high-performance liquid chromatography. J. Chromatogr. B. Biomed. Sci. Appl. 714: 369-374.
25. Prasain, J. K., Jones, K., Brissie, N., Moore, R., Wyss, J. M. & Barnes, S. (2004) Identification of puerarin and its metabolites in rats by liquid chromatography-tandem mass spectrometry. J. Agric. Food Chem. 52: 3708-3712.
26. Datla, K. P., Christidou, M., Widmer, W. W., Rooprai, H. K. & Dexter, D. T. (2001) Tissue distribution and neuroprotective effects of citrus flavonoid tangeretin in a rat model of Parkinson's disease. Neuroreport 12: 3871-3875.
27. Coldham, N. G. & Sauer, M. J. (2000) Pharmacokinetics of [(14)C]genistein in the rat: gender-related differences, potential mechanisms of biological action, and implications for human health. Toxicol. Appl. Pharmacol. 164: 206-215.
28. Chang, H. C., Churchwell, M. I., Delclos, K. B., Newbold, R. R. & Doerge, D. R. (2000) Mass spectrometric determination of genistein tissue distribution in diet-exposed Sprague-Dawley rats. J. Nutr. 130: 1963-1970.
29. Abd El Mohsen, M. M., Kuhnle, G., Rechner, A. R., Schroeter, H., Rose, S., Jenner, P. & Rice-Evans, C. A. (2002) Uptake and metabolism of epicatechin and its access to the brain after oral ingestion. Free Radic. Biol. Med. 33: 1693-1702.
30. Youdim, K. A., Shukitt-Hale, B. & Joseph, J. A. (2004) Flavonoids and the brain: interactions at the blood-brain barrier and their physiological effects on the central nervous system. Free Radic. Biol. Med. 37: 1683-1693.
31. Brown, R. P., Delp, M. D., Lindstedt, S. L., Rhomberg, L. R. & Seules, R. P. (1997) Physiological parameter values for physiologically based pharmacokinetic models. Toxicol. Ind. Health 13: 407-484.
32. Khor, S. P., Bozlgian, H. & Mayersohn, M. (1991) Potential error in the measurement of tissue to blood distribution coefficients in physiological pharmacokinetic modeling. Residual tissue blood. II. Distribution of phencyclidine in the rat. Drug Metab. Dispos. 19: 486-490.
33. Khor, S. P. & Mayersohn, M. (1991) Potential error in the measurement of tissue to blood distribution coefficients in physiological pharmacokinetic modeling. Residual tissue blood. I. Theoretical considerations. Drug Metab. Dispos. 19: 478-485.
34. Giudicelli, C., Dricot, E., Moati, F., Strolin-Benedetti, M. & Giudicelli, J. F. (2004) Is it important to correct apparent drug tissue concentrations for blood contamination in the dog? Fund. Clin. Pharmacol. 18: 281-286.
35. Triplett, J. W., Hayden, T. L., McWhorter, L. K., Gautam, S. R., Kim, E. E. & Bourne, D. W. (1985) Determination of gallium concentration in "blood-free" tissues using a radiolabeled blood marker. J. Pharm. Sci. 74: 1007-1009.
36. Bart, J., Groen, H. J., van der Graaf, W. T., Hollema, H., Hendrikse, N. H., Vaalburci, W., Sleijfer, D. T. & de Vries, E. G. (2002) An oncological view on the blood-testis barrier. Lancet Oncol. 3: 357-363.
37. Bart, J., Hollema, H., Groen, H. J., de Vries, E. G., Hendrikse, N. H., Sleijfer, D. T., Wegman, T. D., Vaalburg, W. & van der Graaf, W. T. (2004) The distribution of drug-efflux pumps, P-gp, BCRP, MRP1 and MRP2, in the normal blood-testis barrier arid in primary testicular tumours. Eur. J. Cancer 40: 2064-2070.
38. Ader, P., Wessmann, A. & Wolffram, S. (2000) Bioavailability and metabolism of the flavonol quercetin in the pig. Free Radic. Biol. Med. 28: 1056-1067.
39. Cermak, R., Landgraf, S. & Wolffram, S. (2003) The bioavailability of quercetin in pigs depends on the glycoside moiety and on dietary factors. J. Nutr. 133: 2802-2807.
40. Manach, C., Morand, C., Demigné, C., Texier, O., Regerat, F. & Rémésy, C. (1997) Bioavailability of rutin and quercetin in rats. FEBS Lett. 409: 12-16.
41. Yuan, L., Wagatsuma, C., Yoshida, M., Miura, T., Mukoda, T., Fujii, H., Sun, B., Kim, J. H. & Surh, Y. J. (2003) Inhibition of human breast cancer growth by GCP (genistein combined polysaccharide) in xenogeneic athymic mice: involvement of genistein biotransformation by beta-glucuronidase from tumor tissues. Mutat. Res. 523-524: 55-62.
42. Shimoi, K., Saka, N., Nozawa, R., Sato, M., Amano, I., Nakayama, T. & Kinae, N. (2001) Deglucuronidation of a flavonoid, luteolin monoglucuronide, during inflammation. Drug Metab. Dispos. 29: 1521-1524.
43. O'Leary, K. A., Day, A. J., Needs, P. W., Mellon, F. A., O'Brien, N. M. & Williamson, G. (2003) Metabolism of quercetin-7- and quercetin-3- glucuronides by an in vitro hepatic model: the role of human [beta]-glucuronidase, sulfotransferase, catechol-O-methyltransferase and multi-resistant protein 2 (MRP2) in flavonoid metabolism. Biochem. Pharmacol. 65: 479-491.